BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38112617)

  • 21. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
    Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
    J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fatty acid synthase in the diagnosis of prostate neoplasms].
    Allina DO; Andreeva YY; Zavalishina LE; Moskvina LV; Frank GA
    Arkh Patol; 2017; 79(2):10-14. PubMed ID: 28418352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenome-wide profiling of DNA methylation in paired samples of adipose tissue and blood.
    Huang YT; Chu S; Loucks EB; Lin CL; Eaton CB; Buka SL; Kelsey KT
    Epigenetics; 2016 Mar; 11(3):227-36. PubMed ID: 26891033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells.
    Wang K; Li L; Jin J; An Y; Wang Z; Zhou S; Zhang J; Abuduaini B; Cheng C; Li N
    J Diabetes Complications; 2022 Jun; 36(6):108159. PubMed ID: 35210136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model.
    Suzuki T; Muramatsu T; Morioka K; Goda T; Mochizuki K
    Nutrition; 2015 Jun; 31(6):877-83. PubMed ID: 25933497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary study on effect of Gegen Qinlian Decoction on enzyme activity, gene expression and methylation level of FASN in adipose tissue of rats with insulin resistance].
    Chen YQ; Gong SF; Huang X; Zeng ZJ; Xu GL; Peng SH; Zhu WF
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(2):398-405. PubMed ID: 33645128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss.
    Bastos DC; Ribeiro CF; Ahearn T; Nascimento J; Pakula H; Clohessy J; Mucci L; Roberts T; Zanata SM; Zadra G; Loda M
    J Pathol; 2021 Mar; 253(3):292-303. PubMed ID: 33166087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
    Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
    EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma.
    Shah US; Dhir R; Gollin SM; Chandran UR; Lewis D; Acquafondata M; Pflug BR
    Hum Pathol; 2006 Apr; 37(4):401-9. PubMed ID: 16564913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase.
    Di Vizio D; Adam RM; Kim J; Kim R; Sotgia F; Williams T; Demichelis F; Solomon KR; Loda M; Rubin MA; Lisanti MP; Freeman MR
    Cell Cycle; 2008 Jul; 7(14):2257-67. PubMed ID: 18635971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
    Kawaguchi K; Kinameri A; Suzuki S; Senga S; Ke Y; Fujii H
    Biochem J; 2016 Feb; 473(4):449-61. PubMed ID: 26614767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.
    Nørgaard M; Haldrup C; Storebjerg TM; Vestergaard EM; Wild PJ; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
    Singh KB; Hahm ER; Kim SH; Wendell SG; Singh SV
    Oncogene; 2021 Jan; 40(3):592-602. PubMed ID: 33199826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
    Wen S; Niu Y; Lee SO; Yeh S; Shang Z; Gao H; Li Y; Chou F; Chang C
    Mol Carcinog; 2016 Dec; 55(12):2278-2290. PubMed ID: 26894509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic effects of FASN, PPARGC1A, ABCG2 and IGF1 revealing the association with milk fatty acids in a Chinese Holstein cattle population based on a post genome-wide association study.
    Li C; Sun D; Zhang S; Yang S; Alim MA; Zhang Q; Li Y; Liu L
    BMC Genet; 2016 Jul; 17():110. PubMed ID: 27468856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
    Khor TO; Fuentes F; Shu L; Paredes-Gonzalez X; Yang AY; Liu Y; Smiraglia DJ; Yegnasubramanian S; Nelson WG; Kong AN
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1186-97. PubMed ID: 25266896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer.
    Xiong Q; Feng D; Wang Z; Ying Y; Xu C; Wei Q; Zeng S; Yang L
    Front Immunol; 2022; 13():836939. PubMed ID: 35392075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
    Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.